Literature DB >> 29395956

Furan and p-xylene as candidate biomarkers for prostate cancer.

Antonio Jiménez-Pacheco1, María Salinero-Bachiller2, María C Iribar2, Alfonso López-Luque1, José L Miján-Ortiz3, Jose M Peinado4.   

Abstract

BACKGROUND: Prostate cancer (PCa) is the most frequently diagnosed noncutaneous malignant tumor among males in the Western world. Prostate-specific antigen has been considered the most important biomarker for PCa detection; however, it lacks specificity, leading to the search for alternative biomarkers. Volatile organic compounds (VOCs) are released during cell metabolism and can be found in exhaled breath, urine, and other fluids. VOCs have been used in the diagnosis of lung, breast, ovarian, and colorectal cancers, among others. The objective of this study was to identify urinary VOCs that may be sensitive and specific biomarkers for PCa.
METHODS: The study included 29 patients with PCa and 21 with benign prostatic hyperplasia. Urine samples were obtained from all participants before and after prostate massage. VOCs were identified by gas chromatography-mass spectrometry. IBM SPSS Statistics v.20 was used for statistical analysis. Sample normality and homogeneity of variances were studied and, according to the distribution normality, ANOVA or the Kruskal-Wallis test was applied to evaluate significant differences between groups. The Pearson test was used to establish correlations.
RESULTS: Fifty-seven VOCs were identified. Samples gathered before prostate massage showed significant between-group differences in urinary levels of furan (P≤ 0.001), 2-ethylhexanol (P = 0.032), 3,5-dimethylbenzaldehyde (P = 0.027), santolin triene (P = 0.032), and 2,6-dimethyl-7-octen-2-ol (P = 0.003). Samples gathered after prostate massage showed significant differences in urinary levels of furan (P≤ 0.001), 3- methylphenol (P = 0.014), p-xylene (P = 0.002), phenol (P≤ 0.001), and 2-butanone (P = 0.001).
CONCLUSIONS: Significant differences between PCa and BPH patients were found in urinary levels of certain VOCs both before and after prostate massage, supporting the proposal that VOCs may serve as PCa-specific biomarkers.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  BPH; Gas chromatography-mass spectrometry; Organic volatile compounds; PCa; Prostatic massage

Mesh:

Substances:

Year:  2018        PMID: 29395956     DOI: 10.1016/j.urolonc.2017.12.026

Source DB:  PubMed          Journal:  Urol Oncol        ISSN: 1078-1439            Impact factor:   3.498


  9 in total

1.  Green Phosphorene as a Promising Biosensor for Detection of Furan and p-Xylene as Biomarkers of Disease: A DFT Study.

Authors:  Aref Aasi; Erfan Aasi; Sadegh Mehdi Aghaei; Balaji Panchapakesan
Journal:  Sensors (Basel)       Date:  2022-04-21       Impact factor: 3.847

Review 2.  Breath analysis as a diagnostic and screening tool for malignant pleural mesothelioma: a systematic review.

Authors:  Lisa Brusselmans; Lieselot Arnouts; Charissa Millevert; Joyce Vandersnickt; Jan P van Meerbeeck; Kevin Lamote
Journal:  Transl Lung Cancer Res       Date:  2018-10

3.  Volatilomics Reveals Potential Biomarkers for Identification of Renal Cell Carcinoma: An In Vitro Approach.

Authors:  Filipa Amaro; Joana Pinto; Sílvia Rocha; Ana Margarida Araújo; Vera Miranda-Gonçalves; Carmen Jerónimo; Rui Henrique; Maria de Lourdes Bastos; Márcia Carvalho; Paula Guedes de Pinho
Journal:  Metabolites       Date:  2020-04-27

4.  Urinary Volatiles and Chemical Characterisation for the Non-Invasive Detection of Prostate and Bladder Cancers.

Authors:  Heena Tyagi; Emma Daulton; Ayman S Bannaga; Ramesh P Arasaradnam; James A Covington
Journal:  Biosensors (Basel)       Date:  2021-11-03

5.  A prediction model using 2-propanol and 2-butanone in urine distinguishes breast cancer.

Authors:  Shoko Kure; Sera Satoi; Toshihiko Kitayama; Yuta Nagase; Nobuo Nakano; Marina Yamada; Noboru Uchiyama; Satoshi Miyashita; Shinya Iida; Hiroyuki Takei; Masao Miyashita
Journal:  Sci Rep       Date:  2021-10-05       Impact factor: 4.379

6.  A Panel of Bile Volatile Organic Compounds Servers as a Potential Diagnostic Biomarker for Gallbladder Cancer.

Authors:  Xin Zhang; Xinru Gui; Yanli Zhang; Qi Liu; Liqiang Zhao; Jingxian Gao; Jian Ji; Yi Zhang
Journal:  Front Oncol       Date:  2022-03-30       Impact factor: 6.244

Review 7.  Volatilomics: An Emerging and Promising Avenue for the Detection of Potential Prostate Cancer Biomarkers.

Authors:  Cristina V Berenguer; Ferdinando Pereira; Jorge A M Pereira; José S Câmara
Journal:  Cancers (Basel)       Date:  2022-08-17       Impact factor: 6.575

8.  Identification of a biomarker panel for improvement of prostate cancer diagnosis by volatile metabolic profiling of urine.

Authors:  Ana Rita Lima; Joana Pinto; Ana Isabel Azevedo; Daniela Barros-Silva; Carmen Jerónimo; Rui Henrique; Maria de Lourdes Bastos; Paula Guedes de Pinho; Márcia Carvalho
Journal:  Br J Cancer       Date:  2019-10-07       Impact factor: 7.640

Review 9.  Advances and Perspectives in Prostate Cancer Biomarker Discovery in the Last 5 Years through Tissue and Urine Metabolomics.

Authors:  Ana Rita Lima; Joana Pinto; Filipa Amaro; Maria de Lourdes Bastos; Márcia Carvalho; Paula Guedes de Pinho
Journal:  Metabolites       Date:  2021-03-19
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.